Publication | Closed Access

An emerging antibacterial nanovaccine for enhanced chemotherapy by selectively eliminating tumor-colonizing bacteria

NanomedicineHealth SciencesMedicineAntibacterial NanovaccineTumor-colonizing BacteriaAntibacterial AgentAntimicrobial ChemotherapyMicrobiologyAntimicrobial CompoundTumor TargetingOncologyRadiation OncologyEnhanced ChemotherapyDrug Resistance